Stock Events

Stock Events

Zai Lab Limited 

$26.55
48
-$0.45-1.67% 08:07 Today

Statistics

Day High
27.04
Day Low
27
52W High
34.72
52W Low
15.96
Volume
20,022
Avg. Volume
-
Mkt Cap
3.03B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.08
-0.05
-0.03
-0
Expected EPS
-0.05438131076
Actual EPS
N/A

Financials

-38.15%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
460.16MRevenue
-175.54MNet Income

Analyst Ratings

38.50Average Price Target
The highest estimate is 45.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZLAB. It's not an investment recommendation.
Microsoft
11
MSFT
NVIDIA
10
NVDA
Meta Platforms
10
META
Alibaba Group
10
BABA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CytomX Therapeutics
CTMX
Mkt Cap699.46M
CytomX Therapeutics operates in the field of oncology, developing Probody therapeutics for the treatment of cancer, competing with Zai Lab's oncology focus.
Exelixis
EXEL
Mkt Cap13.49B
Exelixis is a biotechnology company focused on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers, competing with Zai Lab.
Incyte
INCY
Mkt Cap25.21B
Incyte Corporation specializes in oncology and inflammation, with a portfolio that competes with Zai Lab's product offerings.
Arvinas
ARVN
Mkt Cap600.25M
Arvinas is pioneering the use of proteolysis targeting chimeras (PROTACs) to degrade disease-causing proteins, competing in the innovative treatment space with Zai Lab.
Allogene Therapeutics
ALLO
Mkt Cap697.89M
Allogene Therapeutics focuses on the development of allogeneic CAR T therapies for cancer, which places it in direct competition with Zai Lab's oncology focus.
Novartis
NVS
Mkt Cap292.35B
Novartis is a large pharmaceutical company with a broad oncology portfolio, competing on a global scale with Zai Lab in multiple therapeutic areas.

About

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Show more...
CEO
Ying Du
Employees
1797
Country
Cayman Islands
ISIN
US98887Q1040
WKN
000A2DX1V

Listings

MX
MX
ZLABN.MX
STU
DE
1ZLB.STU
STU
DE
1ZL.STU
STU
DE
1ZLA.STU

0 Comments

Share your thoughts

FAQ

What is Zai Lab Limited stock price today?▼
The current price of ZLAB is $26.55 USD — it has decreased by -1.67% in the past 24 hours. Watch Zai Lab Limited stock price performance more closely on the chart.
What is Zai Lab Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Zai Lab Limited stocks are traded under the ticker ZLAB.
Is Zai Lab Limited stock price growing?▼
ZLAB stock has risen by +3.53% compared to the previous week, the month change is a +46.02% rise, over the last year Zai Lab Limited has showed a -10% decrease.
What is Zai Lab Limited market cap?▼
Today Zai Lab Limited has the market capitalization of 3.03B
When is the next Zai Lab Limited earnings date?▼
Zai Lab Limited is going to release the next earnings report on November 10, 2026.
What were Zai Lab Limited earnings last quarter?▼
ZLAB earnings for the last quarter are -0.05 USD per share, whereas the estimation was -0.07 USD resulting in a +28.05% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Zai Lab Limited revenue for the last year?▼
Zai Lab Limited revenue for the last year amounts to 460.16M USD.
What is Zai Lab Limited net income for the last year?▼
ZLAB net income for the last year is -175.54M USD.
How many employees does Zai Lab Limited have?▼
As of September 04, 2026, the company has 1,797 employees.
In which sector is Zai Lab Limited located?▼
Zai Lab Limited operates in the Health & Wellness sector.
When did Zai Lab Limited complete a stock split?▼
Zai Lab Limited has not had any recent stock splits.
Where is Zai Lab Limited headquartered?▼
Zai Lab Limited is headquartered in SHANGHAI, Cayman Islands.